INE540L01014
INE540L01014
ALKEM LABORATORIES LTD.
Loading chart...
Pure Price Volatility Risk (Market Swings)
The business itself is financially solid (Financial Health 80/100, minimal insolvency risk). The high overall score (6/7) is driven primarily by extreme stock price swings (±23.2% p.a.) and steep historical drawdowns.
Volatility Risk
Transparent evaluation of price volatility (SRI), Beta, and historical drawdowns.
Volatility Risk Score
6/7 High
6 / 7 SRI Price Fluctuation & Beta
Very high volatility or fundamental risks. Significant loss potential; strictly for aggressive investors. Moves noticeably less than the broader market (0.3x).
Beta (Market Relation)
0.29x
DefensiveVolatility (5Y p.a.)
23.2% p.a.
5-Year HorizonMax Drawdown (5Y)
-28.3%
5-Year HorizonSharpe Ratio
0.15
Return / RiskSpeculative / High Risk: Score Basis:
Multi-Horizon Risk & Performance Matrix
Historical volatility, drawdowns, and risk-adjusted return across 1, 3, 5, and 10 years.
Timeframe | Volatility (p.a.) | Max Drawdown | Sharpe Ratio | Return (p.a.) |
|---|---|---|---|---|
| 1 Year | — | — | — | -4.4% |
| 3 Years | 24.1% | -28.3% | 0.47 | +13.9% |
| 5 Years | 23.2% | -28.3% | 0.15 | +5.9% |
| 10 Years | 24.9% | -28.3% | 0.38 | +12% |
Automated Risk & Health Notes (Red Flags)
Single Stock Risk: Investing in an individual stock carries full company and insolvency risk (no fund diversification).
Exemplary balance sheet strength: Very solid ratio of equity to debt.